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Abstract
Objectives: to evaluate orthogeriatric and nurse-led fracture liaison service (FLS) models of post-hip fracture care in terms of
impact on mortality (30 days and 1 year) and second hip fracture (2 years).
Setting: Hospital Episode Statistics database linked to Ofﬁce for National Statistics mortality records for 11 acute hospitals in
a region of England.
Population: patients aged over 60 years admitted for a primary hip fracture from 2003 to 2013.
Methods: each hospital was analysed separately and acted as its own control in a before–after time-series design in which the
appointment of an orthogeriatrician or set-up/expansion of an FLS was evaluated. Multivariable Cox regression (mortality)
and competing risk survival models (second hip fracture) were used. Fixed effects meta-analysis was used to pool estimates of
impact for interventions of the same type.
Results: of 33,152 primary hip fracture patients, 1,288 sustained a second hip fracture within 2 years (age and sex standardised
proportion of 4.2%). 3,033 primary hip fracture patients died within 30 days and 9,662 died within 1 year (age and sex standar-
dised proportion of 9.5% and 29.8%, respectively). The estimated impact of introducing an orthogeriatrician on 30-day and 1-
year mortality was hazard ratio (HR) = 0.73 (95% CI: 0.65–0.82) and HR = 0.81 (CI: 0.75–0.87), respectively. Following an
FLS, these associations were as follows: HR = 0.80 (95% CI: 0.71–0.91) and HR = 0.84 (0.77–0.93). There was no signiﬁcant
impact on time to second hip fracture.
Conclusions: the introduction and/or expansion of orthogeriatric and FLS models of post-hip fracture care has a beneﬁcial
effect on subsequent mortality. No evidence for a reduction in second hip fracture rate was found.
Keywords: epidemiology, hip fracture, fracture liaison service, orthogeriatrician, osteoporosis, older people
Introduction
Hip fracture patients are at an increased risk of both subse-
quent fracture and premature death [1, 2]. An estimated
91,500 hip fractures were expected to occur in the UK during
2015, at a cost in excess of £2 billion (including medical and
social care) [3]. These data indicate the importance of mea-
sures to improve survival and provide better secondary frac-
ture prevention for these patients.
The provision of timely patient care and secondary fracture
prevention for hip fracture patients requires considerable
multi-disciplinary input and organising such a service is
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challenging [4]. Data from randomised controlled trials have
shown signiﬁcant reductions in subsequent fracture risk among
hip fracture patients on antiresorptive treatment [5]. Despite
these data, it is an international phenomenon that contrary to
clinical guideline recommendations, the opportunity to assess
for osteoporosis and initiate treatment among patients after a
fragility fracture remains grossly underutilised [6, 7].
Within this context, fracture liaison services have been
introduced in many countries [8, 9] and are recommended by
the UK Department of Health as a model of best practice
[3]. The British Orthopaedic Association also states that the
complex needs of elderly fracture patients are best addressed
when an orthogeriatrician is ‘fully integrated into the work of
the fracture service’ [3]. However, a recent audit in the UK
found only 37% of local health services provided any kind of
fracture liaison service (FLS) [7], and signiﬁcant variation
exists in how such services are structured [4, 10]. The clinical
effectiveness of such coordinated models of care is emerging
[8]; however, data on key clinical outcomes are scarce [11].
The aim of this study is to use a natural experimental ap-
proach to estimate the clinical effectiveness of orthogeriatric
and nurse-led FLS models of post-hip fracture care on the
risk of second hip fracture and mortality after primary hip
fracture.
Materials and methods
Information on hip fracture hospital admissions was obtained
from the UK hospital episode statistics (HES) database.
Mortality data from the Ofﬁce for National Statistics (ONS)
were linked and extracted using an encrypted patient identiﬁer.
All patient episodes containing an ICD10-code indicating
hip fracture (S72.0, S72.1, S72.2, S72.9) as the primary diagnosis
and with a start date occurring within the study period (1st
April 2003–31st March 2013) were identiﬁed (Supplementary
data, Appendix 1, available in Age and Ageing online). Provider
codes and treatment site codes were used to identify episodes
occurring within the 11 NHS hospitals admitting hip fracture
patients in the region of interest.
The primary outcome of interest was time to second hip
fracture within 2 years of a primary hip fracture. To ensure
this was a separate fracture incident, we counted second hip
fractures only if admitted in a separate ‘continuous inpatient
spell’ and at least 30 days after admission for the primary
fracture. Secondary outcomes of interest were time to death:
(i) within 30 days and (ii) within 1 year following a primary
hip fracture admission. Sample size calculations for these
outcomes are provided in Supplementary data, Appendix 2,
available in Age and Ageing online.
The primary exposure (‘intervention’) was the implementa-
tion within individual hospitals of speciﬁc change to the model
of post-hip fracture care. Information on the nature and timing
of such changes had been obtained through a detailed evalu-
ation of hip fracture services within the 11 hospitals of interest
over the last decade [10].We approached relevant health profes-
sionals within each hospital with a questionnaire we developed
to allow the characterisation of pre-speciﬁed elements of sec-
ondary fracture prevention services over the study period.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Regional summary of primary hip fracture admissions, clinical outcomes and time points of changes to post-hip









30-day mortality 1-year mortality Timepoints of change to post-hip
fracture model of care
N Proportion (%)b N Proportion (%)b N Proportion (%)b Nurse-led FLS Orthogeriatrician
1 3,115 82.9 (8.3) 74.8 146 5.0 309 10.6 949 31.3 – –
2 3,943 82.9 (8.2) 74.2 161 4.4 378 9.9 1,176 30.3 – May 2005,
Aug 2007
3 1,858 82.6 (8.1) 73.6 80 4.2 178 9.7 586 31.2 – –
4 2,819 82.9 (8.3) 75.8 99 4.1 242 9.3 753 28.5 May 2009 Oct 2006
5 1,837 82.8 (8.1) 73.9 56 3.4 154 8.7 528 29.7 – Sept 2009c,d
6 1,030 82.7 (8.1) 73.8 41 4.1 60 5.5 238 22.6 – Nov 2005e
7 5,895 82.8 (8.2) 76.6 206 3.7 489 8.8 1,687 29.2 June 2007d July 2004
8 4,937 83.0 (8.1) 74.3 191 4.0 481 9.7 1,549 31.7 – March 2009
9 1,994 83.1 (8.1) 75.0 76 4.2 194 9.7 562 28.5 April 2005 –
10 4,218 82.9 (8.3) 74.1 154 4.1 417 9.9 1,213 28.9 May 2006, May
2008
Nov 2009c,d
11 1,506 82.7 (8.2) 73.9 78 5.2 131 9 421 29.1 – –
Whole region 33,152 82.9 (8.2) 74.8 1,288 4.2 3,033 9.5 9,662 29.8
aMean (SD).
bAverage proportion, across each financial year under study, of primary hip fracture patients identified as experiencing outcome of interest within the specified time
period (e.g. mortality in 30 days) calculated using financial years 2003/4–2011/12 (mortality) and 2003/4–2010/11 (2-year secondary hip fracture). The proportion
for each financial year was directly standardised using the age and sex structure of the total primary hip fracture population within each hospital (for hospital-specific
proportions) and the region as a whole (for whole region proportion).
cImpact of intervention on hip fracture rate not evaluated due to insufficient post-/pre-intervention data (either owing to another change in service delivery occurring
too close to the intervention or the end of study period (given a 1-year lag would need to be used following an intervention to allow it to take effect)).
dImpact of intervention on 1-year mortality rate not evaluated due to significant pre-intervention trend in 1-year mortality rate.
eImpact of intervention on health outcomes not evaluated within hospital 6 (smallest hospital in the region treating hip fractures) due to high variation in annual
primary hip fracture admissions during the study period.
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Interventions were identiﬁed prior to statistical analysis (Table 1
and Supplementary data, Appendix 3, available in Age and
Ageing online).
Statistical analysis
Survival models were used in a before–after impact analysis.
Time to second hip fracture was estimated for the time period
after each intervention relative to the time period before. Each
hospital was analysed separately (e.g. Supplementary data,
Appendix 4, available in Age and Ageing online). Given that a
high mortality rate could signiﬁcantly overestimate the inci-
dence and effect sizes, the competing risk of death was
accounted for using Fine and Gray regression modelling.
Confounding factors controlled for were age, sex, index of
multiple deprivation score and Charlson-comorbidity index
(none, mild, moderate and severe). It was decided a priori to
exclude from these analyses primary hip fractures admitted
within the 12 months after an intervention in order to account
for a lagged onset of bone protection therapies, and this
excluded 13.3% for the region. Primary hip fracture episodes
starting after 31 March 2011 were not included in the evalua-
tions due to insufﬁcient (i.e. less than 2 years) follow-up. The
assessment of linear trend over time was carried out using a
piecewise Cox proportional hazards model in which linear
splines were ﬁtted to quarterly time points in separate sections
of the time series. The proportional hazards assumption was
checked, using Schoenfeld residuals.
The evaluation of impact on post-fracture mortality was
carried out using a similar approach to above, using multivari-
able Cox proportional hazards regression modelling. We
recognised an inevitable time lag for a newly appointed ortho-
geriatrician to effect systematic change in the care of their
patients with a hip fracture and estimated this at 3 months,
and this excluded 3.3% of patients. Primary hip fracture epi-
sodes were removed from the analyses of 30-day and 1-year
mortality if admitted after 31 December 2012 or 31 March
2012 respectively so as to allow for sufﬁcient follow-up before
the end of the study period.
A ﬁxed-effects meta-analysis was used to pool estimates
of impact on each health outcome under study for orthoger-
iatric and FLS interventions. Estimated impact of interven-
tions with a pre-existing linear trend (P < 0.05) for any of the
health outcomes under study was not included in the corre-
sponding meta-analysis of that health outcome in order to
address the potential bias of secular trend. Statistical analysis
was carried out using the stata v.13.1.
Results
A total of 33,152 hospital episodes were identiﬁed as pertaining
to a primary hip fracture, ranging from 1,030 to 5,895 per hos-
pital of interest (Table 1). The proportion of female admissions
signiﬁcantly changed over time, decreasing from 78.2% (2003/
4) to 72.0% (2012/13). Mean age increased slightly over the
study period from 82.7 years (2003/4) to 83.1 years (2012/13).
There were 1,288 patients identiﬁed as sustaining a second hip
fracture within 2 years from a primary hip fracture, at an
average directly age- and sex-standardised proportion of 4.2%
across ﬁnancial years studied. This proportion remained stable
throughout the study period (P-trend = 0.11). There were
3,033 patients that died within 30 days and 9,662 that died
within 1 year from their primary hip fracture (averaged age-
and sex-standardised proportion across ﬁnancial years studied
of 9.5% and 29.8%, respectively). Overall, age- and sex-
standardised 30-day mortality declined from 11.8% in 2003/4
to 7.1% in 2011/12 (P-trend<0.001) (Figure 1).
Two of the 13 interventions (Table 1 and Supplementary
data, Appendix 3, available in Age and Ageing online) could not
be analysed in relation to time to second hip fracture owing to
insufﬁcient pre- or post-intervention follow-up time once a
12-month lag period was introduced. Three interventions
Figure 1. Annual and quarterly regional trends in mortality
(30-day and 1-year) and second hip fracture (2-year) after
primary hip fracture during the study period.
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were not evaluated in relation to 1-year post-fracture mortality
owing to a pre-intervention trend, i.e. the quarterly rates in
outcome before the intervention were not stable.
The pooled estimated impact of introducing an orthoger-
iatrician on 30-day and 1-year mortality was hazard ratio
(HR) = 0.73 (CI: 0.65–0.82) and HR= 0.81 (CI: 0.75–0.87),
respectively (see Figures 2A and B). Thirty-day and 1-year
mortality were likewise reduced following the introduction of
an FLS: HR = 0.80 (95% CI: 0.71–0.91) and HR= 0.84
(0.77–0.93), respectively.
The reductions in mortality were seen whether introducing
an orthogeriatric or FLS model of care for the ﬁrst time or as
part of an expansion of an existing service. For example, 1-year
mortality was reduced following the appointment of a second
orthogeriatrician within hospital 2 in August 2007 compared
with service delivery during the time with one orthogeriatrician
already in post (HR= 0.78 (95% CI: 0.67–0.91)) (Figure 2B).
Conversely, the sub-hazard ratios (SHRs) from the sur-
vival models showed no evidence for an impact on time to
secondary hip fracture (Figure 2C) following any of the inter-
ventions when analysed separately or when pooled by the
type of intervention: orthogeriatrician (SHR = 0.95 (CI:
0.79–1.15) or FLS (SHR = 1.03 (CI: 0.85–1.26).
Discussion
Main findings
Within this study, we observed an overall decline in mortality
after primary hip fracture across the region as a whole from
2003 to 2011. Despite this increased survivorship, the rate of
second hip fracture remained relatively stable over this time
period. We have demonstrated that the introduction and/or
expansion of orthogeriatric and FLS models of care is signiﬁ-
cantly associated with reduced post-hip fracture mortality.
Assuming a pre-intervention survival of 90% at 30-days and
using the pooled estimates of intervention impact, the number
of patients needed to treat (NNT) to avoid 1 excess death at
30-days is 12 and 17 for orthogeriatric and FLS type interven-
tions. Neither orthogeriatric nor FLS interventions here evalu-
ated had any signiﬁcant impact on time to second hip fracture.
Mortality
We found the average standardised proportion of primary
hip fracture patients dying within 30-days and 1-year to be
9.5 and 29.8%, respectively, which is consistent with previous
reports in a similar population [12, 13], as is the overall down-
ward trend in mortality after hip fracture here identiﬁed
during 2003–11 [14].
A beneﬁcial impact on mortality associated with an ortho-
geriatric model of care is a plausible ﬁnding and is in keeping
with previous studies [15, 16]. It was reported in the pre-
analysis service evaluation that for hospital 8, the appoint-
ment of an orthogeriatric clinical lead meant 90% of hip frac-
ture patients were seen pre-operatively for optimisation for
surgery and that the appointment of a second orthogeriatri-
cian in hospital 2 led to patients being taken to theatre
quicker and in better condition. These are important factors
given previous evidence that trauma-related complications
Figure 2. Forest plot of hazard ratios for outcomes within each
hospital, comparing the time period after relative to the time
period before orthogeriatric or FLS service model interventions
for (A) mortality within 30 days, (B) mortality within 1 year and
(C) second hip fracture following primary hip fracture.
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play a key role in post-hip fracture mortality [17], and that
earlier surgery is associated with lower risk of death [18]. The
beneﬁt of geriatric hip fracture care on delirium has also
been previously demonstrated [19]. Our ﬁndings are consist-
ent with UK NICE clinical guidelines [4] and the British
Orthopaedic Association’s recommendation that ‘senior
medical input from a consultant orthogeriatrician is now es-
sential in the good care of fragility fracture patients’ [3].
The reasons for a reduction in mortality following the
introduction and/or expansion of an FLS are not as clear as
for the orthogeriatric model, although an FLS is likely to
result in an environment of better co-ordination of multi-
disciplinary care with better communication between staff.
The comprehensive assessment and inspection of routine
bloods and medical history that an osteoporosis nurse spe-
cialist carries out may likewise contribute to the identiﬁcation
of secondary diseases and comorbidities. The expected in-
crease in bisphosphonate use may also play a role [20].
Previous studies have reported similar ﬁndings, there
prompting the conclusion that measures to prevent fractures
also reduce mortality [20, 21].
Second hip fracture
Our ﬁnding of an average standardised proportion of 4.2%
for second hip fracture within 2 years of primary hip fracture
is in accord with previous studies [22, 23] although direct
comparisons are difﬁcult due to different lengths of follow-
up time used.
The British Orthopaedic Association states that the most
effective healthcare solution for secondary fracture preventa-
tive assessment is the Fracture Liaison Service, routinely deliv-
ered by a nurse specialist supported by a lead clinician in
osteoporosis [3]. Marsh et al. also report that such systems
appear to be able to overcome barriers to osteoporosis inter-
vention and treatment [9]. It is surprising therefore to ﬁnd a
null effect on hip re-fracture risk in our study. Although, in
general, orthogeriatricians did initiate bone protective therapies
and some nurse specialists were able to make treatment
recommendations that were later prescribed by doctors, one
reason for the lack of observed effect may be patient’s inad-
equate adherence to prescribed therapies. During the period
of the study, the interventions analysed focused on identiﬁca-
tion, investigation and initiation of bone therapy but delegated
monitoring to primary care services. However, patients’ adher-
ence to osteoporosis therapies within the NHS primary care
services is poor, at less than 40% by 12 months [24], and high-
lights the importance of incorporating monitoring within the
scope of a fracture liaison service.
It has been previously noted that the risk of subsequent
fracture after hip fracture can be offset by increased post-
fracture mortality [25], which has elsewhere been used to
explain increasing re-fracture trends during 2000–10 [26]. It
is possible that this dependency of fracture risk on mortality
may be a contributory factor to the apparent lack of impact
on second fracture rate here observed. The high rate of early
re-fracture (35 and 63% within the ﬁrst 6 and 12 months,
respectively), combined with the delayed onset of fracture
risk reduction associated with therapies recommended or
dispensed within the orthogeriatric and FLS models of care
here studied may also have played a role. It has been shown
elsewhere that an FLS may only impact on fracture outcomes
after 15 months [21]; however, in post hoc analyses we found
no signiﬁcant change in pooled estimates of impact on
second fracture between 12 and 36 months after index frac-
ture. The clinical effectiveness of the FLS has been previously
demonstrated in terms of a trend towards improved bone
mineral density testing rates and treatment initiation [8, 9]
although data on the most compelling outcomes such as
re-fracture rates have been rarely reported [11]. Our study
complements other evaluations of FLS initiatives from the
USA [27], Scotland [28], Canada [29] and Australia [30].
Strengths and limitations
A major strength of the present analysis is the use of a
natural experimental design where each hospital acted as its
own control in a before–after impact analysis. The compre-
hensive nature of the HES database allowed for case-mix ad-
justment and a robust deﬁnition of primary hip fracture. A
priori service evaluation ﬁndings provided details on the
timing and nature of all major changes to service delivery of
post-hip fracture care and secondary fracture prevention
during the study period.
Our analysis is subject to various limitations. We were only
able to consider second fractures if associated with a separate
hospital spell. Also, confounding events may have coincided
with interventions of interest although we consider this unlikely
given estimates were consistent across hospitals and for inter-
ventions at different time points. Secular trend may also have
introduced bias into impact estimates; however, this issue was
addressed by excluding from analysis interventions that were
preceded by a signiﬁcant trend in respective health outcomes.
Given the observational nature of the study, residual confound-
ing may have remained, e.g. through the use of our categorised
Charlson score. Furthermore, several aspects of the interven-
tions evaluated were subject to variation (Supplementary data,
Appendix 3, available in Age and Ageing online) which we were
not able to consider in analyses, indicating the possibility that
these various investments might act as proxies for unspeciﬁed
effects associated with general improvement in the quality of
fracture services. Our focus here was on health outcomes after
hip fracture, hence our ﬁndings may not reﬂect the effective-
ness of these models of care among patients having sustained a
non-hip fragility fracture.
Conclusion
In conclusion, this study provides evidence that the introduc-
tion and/or expansion of orthogeriatric and FLS models of
care have a large beneﬁcial effect on subsequent mortality
after hip fracture. There was no evidence for a reduction in
second hip fracture rate, but the effect on non-hip fracture
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remains unanswered as these outcomes cannot be ascer-
tained within the secondary care setting of this study.
Key points
• Orthogeriatric and fracture liaison service models of care
associated with beneﬁcial impact on subsequent mortality.
• There was no evidence for a reduction in the rate of second
hip fracture.
• Impact among non-hip fracture patients and on subsequent
non-hip fracture outcomes remains unanswered.
Supplementary data
Supplementary data mentioned in the text is available to sub-
scribers in Age and Ageing online.
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Abstract
Objective: to evaluate the safety and tolerability of Tilt Testing (TT) and Carotid Sinus Massage (CSM) in octogenarians with
unexplained syncope.
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